-
1دورية أكاديمية
المؤلفون: Aasha I. Hoogland, Reena V. Jayani, Aaron Collier, Nathaly Irizarry‐Arroyo, Yvelise Rodriguez, Michael D. Jain, Margaret Booth‐Jones, Kelly A. Hyland, Brian W. James, Anna Barata, Christina A. Bachmeier, Julio C. Chavez, Farhad Khimani, Gabriel S. Krivenko, Aleksandr Lazaryan, Hien D. Liu, Taiga Nishihori, Javier Pinilla‐Ibarz, Bijal D. Shah, Muneer Abidi, Frederick L. Locke, Heather S. L. Jim
المصدر: Cancer Medicine, Vol 10, Iss 6, Pp 1936-1943 (2021)
مصطلحات موضوعية: behavioral science, hematological cancer, lymphoma, quality of life, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/2045-7634Test
-
2تقرير
المؤلفون: National Cancer Institute (NCI)
المساهمون: Muneer Abidi, Principal Investigator
المصدر: A Phase I Study of Bortezomib During Maintenance Phase After High Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Multiple Myeloma
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00288028Test
-
3تقرير
المؤلفون: National Cancer Institute (NCI)
المساهمون: Muneer Abidi, Principal Investigator
المصدر: Pilot Study Evaluating Aprepitant (MK-869) for Prevention of Nausea & Vomiting Secondary to High Dose Cyclophosphamide Administered to Patients Underging Undergoing Peripheral Hematopoietic Progenitor Cell Mobilization Prior to Autologous Transplantation
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00293384Test
-
4تقرير
المؤلفون: National Cancer Institute (NCI)
المساهمون: Muneer Abidi, Principal Investigator
المصدر: Phase I Dose Escalation Trial of High Dose Melphalan Conditioning Regimen With Palifermin for Cytoprotection Followed by Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00482846Test